Please login to the form below

enasidenib

This page shows the latest enasidenib news and features for those working in and with pharma, biotech and healthcare.

Novartis gets EU nod for leukaemia drug Rydapt

or AML with myelodysplasia-related changes (AML-MRC) – while Celgene/Agios claimed approval for Idhifa (enasidenib) as a treatment for AML patients with the IDH2 mutation.

Latest news

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Idhifa ( enasidenib or AG-221) has been cleared for the treatment of relapsed or refractory acute myeloid leukaemia (AML) in patients with an IDH2 mutation, a group that accounts for somewhere ... At Celgene, enasidenib will slot into its blood cancer
Celgene bags US priority review for cancer metabolism drug

Celgene bags US priority review for cancer metabolism drug. First approval for enasidenib could be just six months away. ... Celgene could be just six months away from getting its first approval for enasidenib, a first-in-class drug for acute myeloid

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Medical Writer: Competitive Salary

New Business Director - PR: Competitive Salary and benefits

Associate Director, Market Access & HEOR – North-West: Negotiable

Account Director: Excellent benefits

Senior Medical Writer: Great salary and benefits

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Associate Editorial Director – Med Comms – London: Salary TBC

Senior Systematic Review Analyst - Oxford: Negotiable

Senior Medical Writer (Remote Working): Competitive Salary Offered

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Medical Writers Required – Cheshire: DOE

Associate Director: £75, 000-90, 000

Consultant Health Economics - London / Oxford: Negotiable

Production Manager – Healthcare Communications: DOE

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Director, Market Access / HEOR - North-West: Negotiable

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Consumer Health Account Director: Circa £60, 000 Gym and More

Account Director: £48, 000 - £60, 000

Project / Account Manager (Medical Education): Salary TBC

Events Manager – Med Comms – Surrey: Salary TBC

Medical Writers: Competitive Salary and Benefits

Scientific Director / Editorial Team Leader: Great salary and benefits

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Subscribe to our email news alerts

PMHub

Add my company

Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health: For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think: Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...